Market Cap 9.26M
Revenue (ttm) 28.54M
Net Income (ttm) -39.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -137.56%
Debt to Equity Ratio -0.66
Volume 23,200
Avg Vol 29,598
Day's Range N/A - N/A
Shares Out 12.30M
Stochastic %K 16%
Beta 0.90
Analysts Sell
Price Target $4.00

Company Profile

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The company's hematology/oncology assets in pipeline include CNCT19, an autologous CD19 CAR-T investiga...

Industry: Biotechnology
Sector: Healthcare
Phone: 86 10 6508 6063
Address:
1701-1702, China Central Office Tower 1, No. 81 Jianguo Road Chaoyang District, Beijing, China
JohnTrack
JohnTrack Dec. 23 at 9:14 PM
$CASI Extension win, still breathing! https://www.rapidticker.com/news/casi-casi-pharmaceuticals-receives-extension-from-a3c371
0 · Reply
JohnTrack
JohnTrack Dec. 11 at 4:18 PM
$CASI better a note than more shares https://www.rapidticker.com/news/casi-casi-pharmaceuticals-announces-up-to-1c795b
0 · Reply
DARKP00L
DARKP00L Dec. 11 at 2:35 PM
$CASI 09:12 on Dec. 11 2025 CASI Pharmaceuticals Secures $20M Convertible Note Investment To Fund Phase 1 Renal Transplant Study In China #tradeideas
0 · Reply
JohnTrack
JohnTrack Dec. 11 at 2:20 PM
$CASI headline ping recorded https://www.rapidticker.com/news/casi-sec-filing-b9f832
0 · Reply
MarketPlumber
MarketPlumber Dec. 9 at 6:39 AM
$CASI china scam
0 · Reply
JohnTrack
JohnTrack Dec. 8 at 3:38 PM
$CASI watching if bids stack...
0 · Reply
ClassiTrader
ClassiTrader Dec. 8 at 3:14 PM
$CASI reported postive results needs volume
0 · Reply
JohnTrack
JohnTrack Dec. 8 at 2:19 PM
$CASI brief note hit the wire https://www.rapidticker.com/news/casi-casi-pharmaceuticals-announces-results-from-2d0f65
0 · Reply
ClassiTrader
ClassiTrader Dec. 5 at 7:39 PM
$CASI swinging .90s
0 · Reply
JGroove
JGroove Nov. 26 at 7:34 PM
$CASI still waiting on that news
1 · Reply
Latest News on CASI
CASI Pharmaceuticals Announces Changes in Board Governance

Nov 19, 2025, 9:00 AM EST - 5 weeks ago

CASI Pharmaceuticals Announces Changes in Board Governance


CASI Pharmaceuticals Appoints James Huang to Board of Directors

Sep 26, 2025, 9:45 AM EDT - 3 months ago

CASI Pharmaceuticals Appoints James Huang to Board of Directors


CASI Pharmaceuticals Provides Business and Clinical Update

May 19, 2025, 9:00 AM EDT - 7 months ago

CASI Pharmaceuticals Provides Business and Clinical Update


CASI PHARMACEUTICALS COMPLETES REDOMICILIATION MERGER

Mar 21, 2023, 4:30 PM EDT - 3 years ago

CASI PHARMACEUTICALS COMPLETES REDOMICILIATION MERGER


JohnTrack
JohnTrack Dec. 23 at 9:14 PM
$CASI Extension win, still breathing! https://www.rapidticker.com/news/casi-casi-pharmaceuticals-receives-extension-from-a3c371
0 · Reply
JohnTrack
JohnTrack Dec. 11 at 4:18 PM
$CASI better a note than more shares https://www.rapidticker.com/news/casi-casi-pharmaceuticals-announces-up-to-1c795b
0 · Reply
DARKP00L
DARKP00L Dec. 11 at 2:35 PM
$CASI 09:12 on Dec. 11 2025 CASI Pharmaceuticals Secures $20M Convertible Note Investment To Fund Phase 1 Renal Transplant Study In China #tradeideas
0 · Reply
JohnTrack
JohnTrack Dec. 11 at 2:20 PM
$CASI headline ping recorded https://www.rapidticker.com/news/casi-sec-filing-b9f832
0 · Reply
MarketPlumber
MarketPlumber Dec. 9 at 6:39 AM
$CASI china scam
0 · Reply
JohnTrack
JohnTrack Dec. 8 at 3:38 PM
$CASI watching if bids stack...
0 · Reply
ClassiTrader
ClassiTrader Dec. 8 at 3:14 PM
$CASI reported postive results needs volume
0 · Reply
JohnTrack
JohnTrack Dec. 8 at 2:19 PM
$CASI brief note hit the wire https://www.rapidticker.com/news/casi-casi-pharmaceuticals-announces-results-from-2d0f65
0 · Reply
ClassiTrader
ClassiTrader Dec. 5 at 7:39 PM
$CASI swinging .90s
0 · Reply
JGroove
JGroove Nov. 26 at 7:34 PM
$CASI still waiting on that news
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 2:55 PM
Results List 11/2025 with 13 trading days to go for this list. $CACC $CASI $BTU $BUD $BTDR
0 · Reply
TwongStocks
TwongStocks Nov. 10 at 9:07 PM
$CASI CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/casi-pharmaceuticals-receives-and-appeals-delisting-determination-fro-1099368 Delist letter received November 5. CASI appealed. The appeal will stay the suspension of the Company's securities pending the outcome of the appeal hearing.
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 4 at 10:58 AM
$CASI Current Stock Price: $1.38 Contracts to trade: $2.5 CASI Nov 21 2025 Call Entry: $2.70 Exit: $5.02 ROI: 86% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DARKP00L
DARKP00L Nov. 3 at 2:44 PM
$CASI 09:15 on Nov. 03 2025 CASI Pharmaceuticals To Present Phase 1 CID-103 Data In Immune Thrombocytopenia At ASH 2025 #tradeideas
0 · Reply
eddiez69
eddiez69 Oct. 31 at 1:10 PM
$CASI This stock is on sale here at this price. I am buyer with limit orders. One piece of news and this will back over $2.00.
0 · Reply
Mr_Bill
Mr_Bill Oct. 29 at 7:34 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 27 at 5:35 PM
$CASI Outstanding article that hits the mark on CASI's current state. So if you want to refresh your CASI insights or learn about CASI from scratch, this is a must read. https://beyondspx.com/quote/CASI/analysis/casi-pharmaceuticals-a-focused-future-on-cid-103-s-immunological-promise-nasdaq-casi
1 · Reply
eddiez69
eddiez69 Oct. 23 at 6:54 PM
$IMMX Volume on this indicates institutional accumulation. Long and strong! YO Small Cap Traders - you MUST LOOK at $CASI - mkt cap is $25.26 Million with only 1.84 Millions shares in float. The team is a who's who in biotech deals with David Cory, new CEO having brought many drugs to market and multiple Billion $ buyouts at other biotechs. Private Placement recently completed on 9/26 at higher price - Panacea and James Huang’s combined effective average cost is about $1.83 per share. No cash issues. Seriously big market for their drug. IMO this is a $7 stock easily See their 13D on edgar https://app.quotemedia.com/data/downloadFiling?webmasterId=102691&ref=319477051&type=HTML&symbol=CASI&cdn=9441db26338e6caf804c7ff41b11286b&companyName=CASI+Pharmaceuticals+Inc.&formType=SCHEDULE+13D&formDescription=General+statement+of+acquisition+of+beneficial+ownership&dateFiled=2025-09-26
0 · Reply
JGroove
JGroove Oct. 22 at 12:53 PM
$CASI guess I am bag holding until the next run
0 · Reply
JGroove
JGroove Oct. 15 at 3:24 PM
$CASI queued
0 · Reply
BullishPiggy
BullishPiggy Oct. 13 at 9:15 PM
$CASI whats this AH bullshit
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 8:00 PM
9/26/25 list Results $CACC $CASI $CADE $CAE $CAG 🔥 Cycle Trading Signal plugged into AI 🔥 list
0 · Reply